Navigation Links
Arpida Announces Agenda Items for Shareholders Meeting
Date:4/15/2008

stant to currently used drugs. Promising results of "first-in-man" studies with AR-709 were published in March 2007.

An additional compound, AR-2474, has achieved in vivo proof of concept. AR-2474 has been shown to be effective in eradicating pathogens in preclinical models of skin infection and nasal carriage.

Apart from the antibiotic programmes, Arpida has an innovative antifungal therapy (TLT) which is in Phase III clinical trials in Europe, targeting onychomycosis.

Moreover, the company has several other leads in optimisation and additional discovery programmes derived from its own discovery platform at various research stages.

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.

Arpida contacts:

Dr Khalid Islam, President and CEO Tel: +41-61-417-96-60

Harry Welten, MBA, CFO and Senior Vice President Tel: +41-61-417-96-65

Paul Verbraeken, Head of Corporate Communications Tel: +41-61-417-96-83


'/>"/>
SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections
2. Arpida Announces Full Year 2007 Financial Results
3. Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
4. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
5. Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
6. Arpida-Supported CME Symposium Available Online
7. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
8. Arpida Presents Preclinical Data on AR-2474 at ICAAC
9. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
10. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
11. Arpida Interim Results for six Months to 30 June 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...r Siemens Biograph mCT supports need for new way o...O, Dec. 1 First introduced at the... October , Siemens Biograph mCT hits the ground r...e current economical situation demands maximum uti...ograph mCT reaches the United States as a pionee...
(Date:12/1/2008)...ERDALE, Fla., Dec. 1 Ima...d: IMDS), a pioneer in laser optical breast,imagi... one of the featured,scientific abstracts at RSNA...,a radiologist at the Tianjin Medical University C... selected for her paper, "CTLM as an Adjunct to Ma...
(Date:12/1/2008)...Dec. 1 The Female Health...arkets the FC Female Condom(R),today reported re...year ended,September 30, 2008. , For the t... increased 52%,to $7.8 million, compared with $5..... The Company reported net income attributable to ...
(Date:12/1/2008)... Calif., Dec. 1 Isis Pha...e following webcast: , , What: New findin...a, microRNA, known as miR-21, in heart...at 8:30 a.m. ET / 5:30 a.m. PT, Where: http...nternet. Simply log onto our website listed above...
Breaking Biology Technology:Imaging in Living Color with Siemens Molecular CT 2Imaging in Living Color with Siemens Molecular CT 3Imaging in Living Color with Siemens Molecular CT 4Imaging Diagnostic Systems CT Laser Mammography (CTLM(R)) System Featured at the 94th Annual Radiological Society of North America (RSNA) Conference 2Imaging Diagnostic Systems CT Laser Mammography (CTLM(R)) System Featured at the 94th Annual Radiological Society of North America (RSNA) Conference 3The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 2The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 3The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 4The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 5The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 6The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 7The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 8
...ery single day of the year, a major corporation is...ch as that the name becomes a liability or is no l...els or technology or trademark litigation. Nonethe... and often very successfully. , ,To change or not ...umber of corporations, big and small, are faced wi...
... biotech infrastructure has prompted a Minnesota c... an operating facility that could employ approxima...ing to the southern tier of Wisconsin to manufactu... company president and CEO Dan Miller. It,s a prod...tial to serve a huge, international market. , ,Exc...
...xpected to pitch their businesses at the upcoming ...s from Wisconsin are now listed as presenters at t...inneapolis. , ,The forum, created through a colla...and the Biotechnology Industry Organization, annua...nd platform companies. , ,New on the forum list ar...
...s, Inc., has become is the first seed lab in the U...edited Seed Lab (ASL) program, administered by th...the company reported Tuesday. , , BioDiagnostics ...esting services. , ,The ASL Program is a voluntar...ratories. Seed testing laboratories, which meet al...
Other Biology Technology:Corporate name change challenges 2Corporate name change challenges 3Corporate name change challenges 4Minneapolis company sets sights on southern Wisconsin 2Minneapolis company sets sights on southern Wisconsin 3Three more Wisconsin firms to present at venture forum 2
(Date:12/1/2008)...ed on epigenetics (the inheritance of propensities...inea nutrient found in eggs and other foodsduring ...utcomes for a mother,s offspring. This finding by ...irst to link choline consumption during pregnancy ... possible choline-related genetic changes that aff...
(Date:11/30/2008)... of "good cholesterol" are good enough, a new stud...EB Journal suggests that you may want to think ag...y of Chicago challenge the conventional wisdom tha...DL) and low levels of bad cholesterol (LDL) is nec... good cholesterol has varying degrees of quality a...
(Date:11/30/2008)...udy describing how cells within blood vessel walls...he age of genomics that the proteins driving cell...ould be near impossible to group them according to... at the Stanford University School of Medicine hav...rol one of four simple activities involved in the ...
(Date:11/27/2008)... A&M Health Science Center Institute of Bioscience...have uncovered how a bacterial pathogen interacts ...ause methicillin-resistant Staphylococcus aureus ...veloping therapeutics against the potentially dead... open-access journal PLoS Pathogens . , Once oc...
Breaking Biology News(10 mins):Eating eggs when pregnant affects breast cancer in offspring 2Cell movements totally modular, Stanford study shows 2Cell movements totally modular, Stanford study shows 3PET CT Brings New Hope to Patients With Deadly Form of Breast Cancer 6986 1PET CT Brings New Hope to Patients With Deadly Form of Breast Cancer 6986 2PET CT Brings New Hope to Patients With Deadly Form of Breast Cancer 6986 3Senator Clintons Plan The Kind of Leadership We Need on AIDS 6983 1Senator Clintons Plan The Kind of Leadership We Need on AIDS 6983 2Hidden Costs Plague Owners Occupying Newly Constructed Buildings 3B New Program Can Help Avoid Major Issues 6980 1Hidden Costs Plague Owners Occupying Newly Constructed Buildings 3B New Program Can Help Avoid Major Issues 6980 2Hidden Costs Plague Owners Occupying Newly Constructed Buildings 3B New Program Can Help Avoid Major Issues 6980 3International Association of Forensic Nurses Announces their 2007 Award Winners 6977 1International Association of Forensic Nurses Announces their 2007 Award Winners 6977 2
...chers at the Johns Hopkins Bloomberg School of Pub...ying specific proteins in whole cell extracts of m...rprinting (PMF). The key to the new method, accord...ing samples that makes PMF faster and more economi...n, they believe PMF can become an economical tool ...
...ific theory holds that Huntington,s disease (HD) i...ain cells and kills them, triggering the genetic n...ric Institute study reveals the first strong evide...eractions from neighboring cells to provoke the fa...ports the findings. , "This is really important be...
...o fought in World War II, the Korean War, and the ...heavy smokers and obese than men who are non-comba...resented at the American Heart Association,s 45th ...miology and Prevention. , "Combat veterans were f...sed to never drinkers than non-veterans, and 1.6 t...
... University researchers may have isolated the subs...follows initial spinal cord injury, a discovery th...er neurodegenerative conditions. , A research team...hemical called acrolein, a known carcinogen, is pr...days after a traumatic injury. Although acrolein i...
Other Biology News:Researchers develop new method for facile identification of proteins in bacterial cells 2New insights into how Huntington's disease attacks the brain 2Male Combat Veterans Rank High In Heart Disease Risk 2Purdue scientists may have found key to halting spinal cord damage 2Purdue scientists may have found key to halting spinal cord damage 3Purdue scientists may have found key to halting spinal cord damage 4
...e Bio-Stack Twister II Microplate Handler is a hig...ution for integrating BioTeks washers, readers and...microplate capacity, ultimate flexibility and intu...g capacity to single devices or linking several mo...
...e STag Purification Kits enable rapid analytical t...n proteins produced from appropriate vectors. Suff...p to 1 mg target protein under native or denaturin...rotein Agarose, which specifically retains STag fu...
...ysical Form: powder ,Components g/500 ml: ,,...ide 2.5 ,Agar 6.0 ,S-Gal 0.125 ,Ferric ammon...5 ,S-Gal/Kanamycin/LB Agar Blend is a comple...esculetin -D-galactopyranoside, a patented autocla...
Useful for determination of glucose and ATP. Packaging: Package sizes are based on hexokinase units. Preparation Unit Definition: One unit will phosphorylate 1.0 mol of D -glucose per min at pH
Biology Products: